These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21256034)

  • 1. Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologies.
    Nemoto T; Yamamoto N; Watanabe A; Fujii H; Hasebe K; Nakajima M; Mochizuki H; Nagase H
    Bioorg Med Chem; 2011 Feb; 19(3):1205-21. PubMed ID: 21256034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a novel 6,14-epoxymorphinan derivative and its pharmacology.
    Nemoto T; Fujii H; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6398-401. PubMed ID: 18990576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of quinolinomorphinan derivatives as highly selective δ opioid receptor ligands.
    Ida Y; Matsubara A; Nemoto T; Saito M; Hirayama S; Fujii H; Nagase H
    Bioorg Med Chem; 2012 Oct; 20(19):5810-31. PubMed ID: 22967810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.
    Nemoto T; Fujii H; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
    Bioorg Med Chem; 2008 Apr; 16(8):4304-12. PubMed ID: 18337104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of pyrrolomorphinan derivatives as kappa opioid agonists.
    Fujii H; Ida Y; Hanamura S; Osa Y; Nemoto T; Nakajima M; Hasebe K; Nakao K; Mochizuki H; Nagase H
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5035-8. PubMed ID: 20685120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Peripheral κ-Opioid Receptor Agonists as Novel Analgesics.
    Suzuki S; Sugawara Y; Inada H; Tsuji R; Inoue A; Tanimura R; Shimozono R; Konno M; Ohyama T; Higashi E; Sakai C; Kawai K
    Chem Pharm Bull (Tokyo); 2017; 65(11):1085-1088. PubMed ID: 29093296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
    Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM
    J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives.
    Suzuki S; Sugawara Y; Tsuji R; Tanimura R; Kaneko C; Yuzawa N; Yagi M; Kawai K
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3920-3924. PubMed ID: 28688957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of quinolinomorphinan-4-ol derivatives as δ opioid receptor agonists.
    Ida Y; Nemoto T; Hirayama S; Fujii H; Osa Y; Imai M; Nakamura T; Kanemasa T; Kato A; Nagase H
    Bioorg Med Chem; 2012 Jan; 20(2):949-61. PubMed ID: 22197670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and structure-activity relationship of novel opioid kappa-agonists.
    Kawai K; Hayakawa J; Miyamoto T; Imamura Y; Yamane S; Wakita H; Fujii H; Kawamura K; Matsuura H; Izumimoto N; Kobayashi R; Endo T; Nagase H
    Bioorg Med Chem; 2008 Oct; 16(20):9188-201. PubMed ID: 18829333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, δ opioid receptor agonists.
    Nemoto T; Ida Y; Iihara Y; Nakajima R; Hirayama S; Iwai T; Fujii H; Nagase H
    Bioorg Med Chem; 2013 Dec; 21(24):7628-47. PubMed ID: 24262888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of KNT-127, a δ-opioid receptor agonist effective by systemic administration.
    Nagase H; Nemoto T; Matsubara A; Saito M; Yamamoto N; Osa Y; Hirayama S; Nakajima M; Nakao K; Mochizuki H; Fujii H
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6302-5. PubMed ID: 20850307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and opioid receptor activity of indolopropellanes.
    Li F; Gaob L; Yin C; Chen J; Liu J; Xie X; Zhang A
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4603-6. PubMed ID: 19595591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.
    Neumeyer JL; Zhang A; Xiong W; Gu XH; Hilbert JE; Knapp BI; Negus SS; Mello NK; Bidlack JM
    J Med Chem; 2003 Nov; 46(24):5162-70. PubMed ID: 14613319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential structure of opioid κ receptor agonist nalfurafine for binding to the κ receptor 3: synthesis of decahydro(iminoethano)phenanthrene derivatives with an oxygen functionality at the 3-position and their pharmacologies.
    Fujii H; Imaide S; Hirayama S; Nemoto T; Gouda H; Hirono S; Nagase H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7711-4. PubMed ID: 23103094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.
    Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
    Chem Biol Drug Des; 2009 Oct; 74(4):335-42. PubMed ID: 19691470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.
    Greiner E; Spetea M; Krassnig R; Schüllner F; Aceto M; Harris LS; Traynor JR; Woods JH; Coop A; Schmidhammer H
    J Med Chem; 2003 Apr; 46(9):1758-63. PubMed ID: 12699394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.